NGM Biopharmaceuticals Inc (NGM) Stock Gains 12.15% This Week: Is It a Good Pick?
Monday, October 02, 2023 10:24 AM | InvestorsObserver Analysts
Mentioned in this article
NGM Biopharmaceuticals Inc (NGM) stock is down -90.53% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives NGM stock a score of 33 out of a possible 100.
That rank is primarily influenced by a short-term technical score of 1. NGM's rank also includes a long-term technical score of 3.
NGM has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on NGM!
NGM Biopharmaceuticals Inc (NGM) stock is up 12.15% while the S&P 500 is down -0.03% as of 10:23 AM on Monday, Oct 2. NGM has risen $0.13 from the previous closing price of $1.07 on volume of 279,250 shares. Over the past year the S&P 500 is higher by 16.53% while NGM is down -90.53%. NGM lost -$2.08 per share in the over the last 12 months.
Click Here to get the full Stock Report for NGM Biopharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter